American College of Radiology ACR Appropriateness Criteria HODGKIN LYMPHOMA — UNFAVORABLE CLINICAL STAGE I AND II Expert Panel on Radiation Oncology–Lymphoma:

نویسندگان

  • Kenneth B. Roberts
  • Anas Younes
  • David C. Hodgson
  • Ranjana Advani
  • Bouthaina S. Dabaja
  • Christopher R. Flowers
  • Chul S. Ha
  • Monika L. Metzger
  • Sonali M. Smith
  • Stephanie A. Terezakis
چکیده

Expert Panel on Radiation Oncology–Lymphoma: Kenneth B. Roberts, MD; Anas Younes, MD; David C. Hodgson, MD; Ranjana Advani, MD; Bouthaina S. Dabaja, MD; Sughosh Dhakal, MD; Christopher R. Flowers, MD, MS; Chul S. Ha, MD; Bradford S. Hoppe, MD, MPH; Nancy P. Mendenhall, MD; Monika L. Metzger, MD; John P. Plastaras, MD, PhD; Ronald Shapiro, MD; Sonali M. Smith, MD; Stephanie A. Terezakis, MD; Karen M. Winkfield, MD, PhD; Louis S. Constine, MD.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.

This topic addresses the treatment of newly diagnosed patients with favorable prognosis stage I and II Hodgkin lymphoma. In most cases, combined modality therapy (chemotherapy followed by involved site radiation therapy) constitutes the current standard of care. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are rev...

متن کامل

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

These guidelines review the historical evolution of treatment for early-stage Hodgkin lymphoma (HL) with current standards that rely on prognostic factors to risk stratify and direct current treatment schemes that includes differentiation of favorable and unfavorable presentations. The major clinical trials for unfavorable early-stage HL are reviewed. Patients in this heterogenous subgroup of c...

متن کامل

ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer.

OBJECTIVE The use of adjuvant treatment(s) following initial hysterectomy and retroperitoneal nodal harvesting of patients with clinical stage I and II cervical carcinoma is (are) presently based on the pathological assessment of surgical specimens. This report sought to delineate further the clinical application of potential therapeutic interventions and associated follow-up investigations of ...

متن کامل

American College of Radiology ACR Appropriateness Criteria ROLE OF ADJUVANT THERAPY IN THE MANAGEMENT OF EARLY STAGE CERVICAL CANCER Expert Panel on Radiation Oncology–Gynecology:

Background on Surgical Management For over 100 years, radical hysterectomy has been the preferred surgical method for treating early (International Federation of Gynecology and Obstetrics [FIGO] clinical stages I and II) cervical carcinoma. The first radical hysterectomy operation was described by John G. Clark, resident gynecologist under Howard Kelly at the Johns Hopkins Hospital in 1895. In ...

متن کامل

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

The purpose of this work was to modernize recommendations for evaluation, staging, and response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). A workshop was held at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland, in June 2011, that included leading hematologists, oncologists, radiation oncologists, pathologists, radiologists, a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015